Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation

Journal of Physiology

Volumn 594, Issue 20, 2016, Pages 5781-5790

  Bonaz, Bruno ^a,b   Sinniger, Valérie ^a,b   Pellissier, Sonia ^a,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

^c UNIVERSITÉ DE SAVOIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACETYLCHOLINE; BETA 2 ADRENERGIC RECEPTOR; BUNGAROTOXIN RECEPTOR; GALANTAMINE; HYDROCORTISONE; NORADRENALIN; SEMAPIMOD; TUMOR NECROSIS FACTOR;

ACETYLCHOLINE RELEASE; AFFERENT NERVE GROUP 1; ANTIINFLAMMATORY ACTIVITY; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC NERVE; CHRONIC INFLAMMATION; EFFERENT NERVE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART RATE VARIABILITY; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATORY BOWEL DISEASE; MACROPHAGE; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RHEUMATOID ARTHRITIS; SENSORY NERVE; SOLITARY TRACT NUCLEUS; SPLENIC T CELL; SYMPATHETIC NERVE; SYNAPSE; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84991239671     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271539     Document Type: Review

References (71)

1. Altschuler SM, Escardo J, Lynn RB & Miselis RR (1993). The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology 104, 502–509.
2. Bellinger DL, Felten SY, Lorton D & Felten DL (1989). Origin of noradrenergic innervation of the spleen in rats. Brain Behav Immun 3, 291–311.
3. Benarroch EE (1993). The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 68, 988–1001.
4. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ & Tracey KJ (2002a). Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 36, 1231–1236.
5. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM & Tracey KJ (2002b). Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 195, 781–788.
6. Berthoud HR, Carlson NR & Powley TL (1991). Topography of efferent vagal innervation of the rat gastrointestinal tract. Am J Physiol Regul Integr Comp Physiol 260, R200–R207.
7. Berthoud HR & Powley TL (1993). Characterization of vagal innervation to the rat coeliac, suprarenal and mesenteric ganglia. J Auton Nerv Syst 42, 153–169.
8. Berthoud HR & Powley TL (1996). Interaction between parasympathetic and sympathetic nerves in prevertebral ganglia: morphological evidence for vagal efferent innervation of ganglion cells in the rat. Microsc Res Tech 35, 80–86.
9. Bonaz B, Picq C, Sinniger V, Mayol JF & Clarencon D (2013). Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 25, 208–221.
10. Bonaz B, Sinniger V, Hoffmann D, Clarençon D, Mathieu N, Dantzer C, Vercueil L, Picq C, Trocmé C, Faure P, Cracowski JL & Pellissier S (2016). Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. Neurogastroenterol Motil; DOI: 10.1111/nmo.12792.
11. Bonaz BL & Bernstein CN (2013). Brain–gut interactions in inflammatory bowel disease. Gastroenterology 144, 36–49.
12. Borovikova LV, Ivanova S, Nardi D, Zhang M, Yang H, Ombrellino M & Tracey KJ (2000a). Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 85, 141–147.
13. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW & Tracey KJ (2000b). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462.
14. Bratton BO, Martelli D, McKinley MJ, Trevaks D, Anderson CR & McAllen RM (2012). Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons. Exp Physiol 97, 1180–1185.
15. Buijs RM, van der Vliet J, Garidou ML, Huitinga I & Escobar C (2008). Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS One 3, e3152.
16. Buller KM (2001). Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic–pituitary–adrenal axis. Clin Exp Pharmacol Physiology 28, 581.
17. Cailotto C, Gomez-Pinilla PJ, Costes LM, van der Vliet J, Di Giovangiulio M, Nemethova A, Matteoli G & Boeckxstaens GE (2014). Neuro-anatomical evidence indicating indirect modulation of macrophages by vagal efferents in the intestine but not in the spleen. PLoS One 9, e87785.
18. Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW & Chrousos GP (1992). Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 55, 600–608.
19. Cechetto DF (1987). Central representation of visceral function. Fed Proc 46, 17–23.
20. Clarencon D, Pellissier S, Sinniger V, Kibleur A, Hoffman D, Vercueil L, David O & Bonaz B (2014). Long term effects of low frequency (10 Hz) vagus nerve stimulation on EEG and heart rate variability in Crohn's disease: a case report. Brain Stimul 7, 914–916.
21. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM & Boeckxstaens GE (2005). Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6, 844–851.
22. Delmas J & Laux G (1933). Anatomie médico-chirurgicale du système nerveux végétatif: sympathique & parasympathique. Paris, Masson.
23. Downs AM, Bond CE & Hoover DB (2014). Localization of alpha7 nicotinic acetylcholine receptor mRNA and protein within the cholinergic anti-inflammatory pathway. Neuroscience 266, 178–185.
24. Englot DJ, Chang EF & Auguste KI (2011a). Efficacy of vagus nerve stimulation for epilepsy by patient age, epilepsy duration, and seizure type. Neurosurg Clin N Am 22, 443–448, v.
25. Englot DJ, Chang EF & Auguste KI (2011b). Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg 115, 1248–1255.
26. Gamus D (2011). [Cholinergic anti-inflammatory pathway of some non-pharmacological therapies of complementary medicine: possible implications for treatment of rheumatic and autoimmune diseases]. Harefuah 150, 660–663, 687.
27. Gautron L, Rutkowski JM, Burton MD, Wei W, Wan Y & Elmquist JK (2013). Neuronal and nonneuronal cholinergic structures in the mouse gastrointestinal tract and spleen. J Comp Neurol 521, 3741–3767.
28. George MS, Nahas Z, Bohning DE, Kozel FA, Anderson B, Chae JH, Lomarev M, Denslow S, Li X & Mu C (2002). Vagus nerve stimulation therapy: a research update. Neurology 59, S56–61.
29. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF & Collins SM (2006). The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131, 1122–1130.
30. Heffernan KS, Jae SY, Vieira VJ, Iwamoto GA, Wilund KR, Woods JA & Fernhall B (2009). C-reactive protein and cardiac vagal activity following resistance exercise training in young African–American and white men. Am J Physiol Regul Integr Comp Physiol 296, R1098–R1105.
31. Hosoi T, Okuma Y, Matsuda T & Nomura Y (2005). Novel pathway for LPS-induced afferent vagus nerve activation: Possible role of nodose ganglion. Auton Neurosci 120, 104–107.
32. Jae SY, Carnethon MR, Heffernan KS, Fernhall B, Lee MK & Park WH (2009a). Heart rate recovery after exercise and incidence of type 2 diabetes in men. Clin Auton Res 19, 189–192.
33. Jae SY, Heffernan KS, Yoon ES, Lee MK, Fernhall B & Park WH (2009b). The inverse association between cardiorespiratory fitness and C-reactive protein is mediated by autonomic function: a possible role of the cholinergic antiinflammatory pathway. Mol Med 15, 291–296.
34. Ji H, Rabbi MF, Labis B, Pavlov VA, Tracey KJ & Ghia JE (2014). Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol 7, 335–347.
35. Johnston GR & Webster NR (2009). Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth 102, 453–462.
36. Koopman FA, Schuurman PR, Vervoordeldonk MJ & Tak PP (2014). Vagus nerve stimulation: a new bioelectronics approach to treat rheumatoid arthritis? Best Pract Res Clin Rheumatol 28, 625–635.
37. Krahl SE, Senanayake SS & Handforth A (2001). Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 42, 586–589.
38. Lomarev M, Denslow S, Nahas Z, Chae JH, George MS & Bohning DE (2002). Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res 36, 219–227.
39. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH & Buurman WA (2005). Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 202, 1023–1029.
40. Mao Y, Cheng J, Yu F, Li H, Guo C & Fan X (2015a). Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-kappaB inhibition. Cell Physiol Biochem 37, 563–576.
41. Mao Y, Tokudome T, Kishimoto I, Otani K, Nishimura H, Yamaguchi O, Otsu K, Miyazato M & Kangawa K (2015b). Endogenous ghrelin attenuates pressure overload-induced cardiac hypertrophy via a cholinergic anti-inflammatory pathway. Hypertension 65, 1238–1244.
42. Mao Y, Wang J, Yu F, Cheng J, Li H, Guo C & Fan X (2015c). Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice. Drug Des Devel Ther 9, 5385–5396.
43. Martelli D, McKinley MJ & McAllen RM (2014). The cholinergic anti-inflammatory pathway: a critical review. Auton Neurosci 182, 65–69.
44. Matteoli G, Gomez-Pinilla PJ, Nemethova A, Di Giovangiulio M, Cailotto C, van Bree SH, Michel K, Tracey KJ, Schemann M, Boesmans W, Vanden Berghe P & Boeckxstaens GE (2014). A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut 63, 938–948.
45. Meregnani J, Clarencon D, Vivier M, Peinnequin A, Mouret C, Sinniger V, Picq C, Job A, Canini F, Jacquier-Sarlin M & Bonaz B (2011). Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 160, 82–89.
46. Mikkelsen HB, Thuneberg L, Rumessen JJ & Thorball N (1985). Macrophage-like cells in the muscularis externa of mouse small intestine. Anat Rec 213, 77–86.
47. Morris GL 3rd & Mueller WM (1999). Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 53, 1731–1735.
48. − T cells in experimental colitis. PLoS One 9, e109272.
49. Netter FH (1989). Atlas of Human Anatomy. Ciba-Geigy Corporation. Ardsley, USA.
50. Olofsson PS, Katz DA, Rosas-Ballina M, Levine YA, Ochani M, Valdes-Ferrer SI, Pavlov VA, Tracey KJ & Chavan SS (2012). α-7-Nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol Med 18, 539–543.
51. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, Ochani M, Ochani K, Yang LH, Hudson L, Lin X, Patel N, Johnson SM, Chavan S, Goldstein RS, Czura CJ, Miller EJ, Al-Abed Y, Tracey KJ & Pavlov VA (2008). Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 14, 567–574.
52. Pavlov VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, Ochani K, Chavan S, Al-Abed Y & Tracey KJ (2009). Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23, 41–45.
53. Pavlov VA & Tracey KJ (2015). Neural circuitry and immunity. Immunol Res 63, 38–57.
54. Pavlov VA, Wang H, Czura CJ, Friedman SG & Tracey KJ (2003). The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9, 125–134.
55. Pellissier S, Dantzer C, Canini F, Mathieu N & Bonaz B (2010). Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome. Psychoneuroendocrinology 35, 653–662.
56. Pellissier S, Dantzer C, Mondillon L, Trocme C, Gauchez AS, Ducros V, Mathieu N, Toussaint B, Fournier A, Canini F & Bonaz B (2014). Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome. PLoS One 9, e105328.
57. Pena G, Cai B, Liu J, van der Zanden EP, Deitch EA, de Jonge WJ & Ulloa L (2010). Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis. Eur J Immunol 40, 2580–2589.
58. Peuker ET & Filler TJ (2002). The nerve supply of the human auricle. Clin Anat 15, 35–37.
59. Reyt S, Picq C, Sinniger V, Clarencon D, Bonaz B & David O (2010). Dynamic Causal Modelling and physiological confounds: a functional MRI study of vagus nerve stimulation. Neuroimage 52, 1456–1464.
60. Ricardo JA & Koh ET (1978). Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res 153, 1–26.
61. Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM, Chavan S & Tracey KJ (2008). Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 105, 11008–11013.
62. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW & Tracey KJ (2011). Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98–101.
63. Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M, Kasper BS, Hammen T, Rzonsa M, Pauli E, Ellrich J, Graf W & Hopfengartner R (2012). Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 53, e115–118.
64. Strack AM, Sawyer WB, Hughes JH, Platt KB & Loewy AD (1989a). A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res 491, 156–162.
65. Strack AM, Sawyer WB, Platt KB & Loewy AD (1989b). CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 491, 274–296.
66. Thayer JF & Lane RD (2009). Claude Bernard and the heart–brain connection: further elaboration of a model of neurovisceral integration. Neurosci Biobehav Rev 33, 81–88.
67. The FO, Boeckxstaens GE, Snoek SA, Cash JL, Bennink R, Larosa GJ, van den Wijngaard RM, Greaves DR & de Jonge WJ (2007). Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 133, 1219–1228.
68. van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ & van der Poll T (2006). The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822–1830.
69. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ & Tracey KJ (2003). Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384–388.
70. Werner MFP, Fraga D, Melo MCC, Souza GEP & Zampronio AR (2003). Importance of the vagus nerve for fever and neutrophil migration induced by intraperitoneal LPS injection. Inflammation Research 52, 291–296.
71. Zagon A (2001). Does the vagus nerve mediate the sixth sense? Trends Neurosci 24, 671–673.